Hostname: page-component-848d4c4894-2xdlg Total loading time: 0 Render date: 2024-06-14T15:56:37.010Z Has data issue: false hasContentIssue false
  • English
  • Français

Clarification Regarding Generic Substitution for Psychotropic Drugs

Published online by Cambridge University Press:  07 November 2014

Pierre Blier
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letter to the Editor
Information
CNS Spectrums , Volume 14 , Issue 12 , December 2009 , pp. 709 - 710
Copyright
Copyright © Cambridge University Press 2009

References

REFERENCE

1. Food and Drug Administration Electronic Orange Book. Approved Drug Products With Therapeutic Equivalence Evaluations. Patent and Exclusivity Search Results from query on Appl No 021323 Product 001 in the OB_Rx list. Available at: www.accessdata.fda.gov/scripts/cder/ob/docs/patexclnew.cfm?Appl_No=021323&Product_No=001&table1=0B_Rx. Accessed November 19, 2009.Google Scholar